Axsome Therapeutics Stock (NASDAQ:AXSM), Quotes and News Summary

Q: What sector and industry does Axsome Therapeutics (AXSM) operate in?

Axsome Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Axsome Therapeutics Stock (NASDAQ: AXSM) stock price, news, charts, stock research, profile.

Open	$69.440
Close	$65.720
Volume / Avg.	834.897K / 723.469K
Day Range	65.607 - 70.078
52 Wk Range	55.020 - 98.400
Market Cap	$3.136B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	19.44%
Days to Cover	10.36

Recent News

Tesla To $120? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Avi Kapoor

What's Going On Neurology-Focused Axsome Therapeutics' Stock On Monday?

Unlock insights from the SYMPHONY Phase 3 trial of AXS-12 (reboxetine) in narcolepsy patients. AXS-12 demonstrated significant reductions in cataplexy attacks, improved daytime wakefulness, and cognitive function.

Vandana Singh

Neurology-Focused Axsome Therapeutics Reports Deeper Than Expected Q4 Loss, Updates Upcoming Pipeline Milestones

Axsome Therapeutics Q4 2023 revenues surge to $71.53 million, Auvelity sales hit $130.1 million for the year. Sunosi sees 67% YoY growth.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Axsome Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing n...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Axsome Therapeutics (AXSM) stock?

You can purchase shares of Axsome Therapeutics (NASDAQ: AXSM) through any online brokerage.

View our list of the best stock brokerages.

Who are Axsome Therapeutics's (AXSM) competitors?

Other companies in Axsome Therapeutics’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

What is the target price for Axsome Therapeutics (AXSM) stock?

The latest price target for Axsome Therapeutics (NASDAQ: AXSM) was reported by Cantor Fitzgerald on Wednesday, April 10, 2024. The analyst firm set a price target for 107.00 expecting AXSM to rise to within 12 months (a possible 61.63% upside). 43 analyst firms have reported ratings in the last year.

Current Stock Price for Axsome Therapeutics (AXSM)?

The stock price for Axsome Therapeutics (NASDAQ: AXSM) is $66.2 last updated April 18, 2024 at 7:25 PM EDT.

Does Axsome Therapeutics (AXSM) pay a dividend?

There are no upcoming dividends for Axsome Therapeutics.

When is Axsome Therapeutics (NASDAQ:AXSM) reporting earnings?

Axsome Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.

Is Axsome Therapeutics (AXSM) going to split?

There is no upcoming split for Axsome Therapeutics.

What sector and industry does Axsome Therapeutics (AXSM) operate in?

Axsome Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-